论文部分内容阅读
多种生长因子及其受体之间的相互作用在恶性肿瘤的发生与发展中起着很关键的作用。表皮生长因子受体 (ｅｐｉ ｄｅｒｍａｌｇｒｏｗｔｈｆａｃｔｏｒｒｅｃｅｐｔｏｒ,ＥＧＦＲ)作为肿瘤治疗的新靶点 ,其研究已历时 2 0余年。近期 ,可以有效抑制ＥＧＦＲ的生物及化学制剂正在逐
The interaction between various growth factors and their receptors plays a key role in the development and progression of malignant tumors. Epidermal growth factor receptor (epi dermalgrowthfactorreceptor, EGFR) as a new target for cancer treatment, the study has lasted 20 years. Recently, the biological and chemical agents that can effectively inhibit EGFR are on the way